Clinical trial
Non-small Cell Lung Cancer Registry
NCT00099541
Study timeline
Study start (unknown)2004-11-01Date precision: month
Registry last updated2009-11-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-Small-Cell Lung Cancerunresolved
Pleural Effusion, Malignantunresolved
Interventions
zoledronic acidDRUG · verified · RxNorm: zoledronic acid
Sponsors & collaborators
Novartis Pharmaceuticalslead sponsor
Mapped research locations
MemphisTennessee, United States3BaltimoreMaryland, United States2St LouisMissouri, United States2Las VegasNevada, United States2New YorkNew York, United States1HoustonTexas, United States1DallasTexas, United States1San AntonioTexas, United States1SeattleWashington, United States1BirminghamAlabama, United States1CincinnatiOhio, United States1JacksonvilleFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00099541 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.